Søgaard Stinne Byrholdt, Andersen Sofie Bech, Taghavi Iman, Schou Mikkel, Christoffersen Christina, Jacobsen Jens Christian Brings, Kjer Hans Martin, Gundlach Carsten, McDermott Amy, Jensen Jørgen Arendt, Nielsen Michael Bachmann, Sørensen Charlotte Mehlin
Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Department of Diagnostic Radiology, Rigshospitalet, 2100 Copenhagen, Denmark.
Diagnostics (Basel). 2023 Oct 12;13(20):3197. doi: 10.3390/diagnostics13203197.
Individuals with diabetes at risk of developing diabetic kidney disease (DKD) are challenging to identify using currently available clinical methods. Prognostic accuracy and initiation of treatment could be improved by a quantification of the renal microvascular rarefaction and the increased vascular tortuosity during the development of DKD. Super-resolution ultrasound (SRUS) imaging is an in vivo technique capable of visualizing blood vessels at sizes below 75 µm. This preclinical study aimed to investigate the alterations in renal blood vessels' density and tortuosity in a type 2 diabetes rat model, Zucker diabetic fatty (ZDF) rats, as a prediction of DKD. Lean age-matched Zucker rats were used as controls. A total of 36 rats were studied, subdivided into ages of 12, 22, and 40 weeks. Measured albuminuria indicated the early stage of DKD, and the SRUS was compared with the ex vivo micro-computed tomography (µCT) of the same kidneys. Assessed using the SRUS imaging, a significantly decreased cortical vascular density was detected in the ZDF rats from 22 weeks of age compared to the healthy controls, concomitant with a significantly increased albuminuria. Already by week 12, a trend towards a decreased cortical vascular density was found prior to the increased albuminuria. The quantified vascular density in µCT corresponded with the in vivo SRUS imaging, presenting a consistently lower vascular density in the ZDF rats. Regarding vessel tortuosity, an overall trend towards an increased tortuosity was present in the ZDF rats. SRUS shows promise for becoming an additional tool for monitoring and prognosing DKD. In the future, large-scale animal studies and human trials are needed for confirmation.
对于有患糖尿病肾病(DKD)风险的糖尿病患者,使用目前可用的临床方法进行识别具有挑战性。通过量化DKD发展过程中的肾微血管稀疏和血管迂曲增加,可以提高预后准确性和治疗的启动。超分辨率超声(SRUS)成像是一种能够在体内可视化尺寸小于75μm血管的技术。这项临床前研究旨在调查2型糖尿病大鼠模型——Zucker糖尿病脂肪大鼠(ZDF大鼠)肾血管密度和迂曲的变化,以此作为DKD的预测指标。将年龄匹配的瘦型Zucker大鼠作为对照。总共研究了36只大鼠,分为12周、22周和40周龄三组。测量的蛋白尿表明处于DKD早期,将SRUS与同一肾脏的离体微型计算机断层扫描(µCT)进行比较。使用SRUS成像评估发现,与健康对照相比,22周龄起ZDF大鼠的皮质血管密度显著降低,同时蛋白尿显著增加。早在第12周,在蛋白尿增加之前就发现了皮质血管密度降低的趋势。µCT中量化的血管密度与体内SRUS成像结果一致,显示ZDF大鼠的血管密度始终较低。关于血管迂曲,ZDF大鼠总体上存在迂曲增加的趋势。SRUS有望成为监测和预测DKD的另一种工具。未来,需要进行大规模动物研究和人体试验来加以证实。